DJIA 17,148.24 117.10 0.69%
NASDAQ 4,555.76 36.86 0.82%
S&P 500 2,000.20 16.07 0.81%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

73.23 1.28 (1.78%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $73.23 1.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.80
Previous Close $71.95
Daily Range $70.55 - $73.52
52-Week Range $47.03 - $112.57
Market Cap $5.6B
P/E Ratio -14.08
Dividend (Yield) $0.00 (0.0%)
Volume 578,663
Average Daily Volume 544,561
Current FY EPS -$5.37

Sector

Healthcare

Industry

Drugs

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary Rss Feed

Growth and Dividends: Europe's Best Pharma Stock

Read below to find out which stock it is.

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog

Tekmira: Much More Than An Ebola Treatment

Alnylam Broadens Pipeline With ALN-AGT, A Subcutaneously Administered RNAi Therapeutic Targeting Ang

Alnylam Broadens Pipeline With ALN-AGT, A Subcutaneously Administered RNAi Therapeutic Targeting Angiotensinogen For The Treatment Of Hypertensive Disorders Of Pregnancy, Including Preeclampsia

ALNY Makes Notable Cross Below Critical Moving Average

Gilead: Let's Make A Deal

Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY

Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus - Analyst Blog

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

Alnylam Pharmaceuticals Has Plenty On Its Plate

Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q2 2014 Results - Earnings Call Transcript

See More ALNY News...

ALNY's Top Competitors

ALNY $73.23 (1.78%)
Current stock: ALNY
AMGN $139.31 (0.97%)
Current stock: AMGN
GILD $104.67 (3.64%)
Current stock: GILD
BIIB $327.56 (2.32%)
Current stock: BIIB